Hormone pill may cut heart risk in perimenopause, small study suggests
Disease control
Completed
This completed Phase 3 trial tested whether taking 50 mg of prasterone (DHEA) daily for 2 months could improve cardiometabolic indicators in perimenopausal women. The study enrolled 25 women and measured changes in insulin resistance and lipid levels. The goal is to find a way to…
Phase: PHASE3 • Sponsor: Universidad de Guanajuato • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC